TORIPALIMAB
UNII 8JXN261VVA

Substance Identification & Data

This profile provides standardized clinical and technical data for Toripalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8JXN261VVA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1924598-82-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8JXN261VVA

CAS Registry Number

1924598-82-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TORIPALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

8JXN261VVA

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C131334

National Cancer Institute reference terminology for clinical and research data.

INN ID

10820

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-170

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Toripalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TORIPALIMAB

TORIPALIMAB-TPZI

Common Names & Synonyms

ANTI-PD-I MAB-SHANGHAI JUNSHI

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JS001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS001 .KAPPA.-CHAIN, DIMER

TERIPRIZUMAB

TORIPALIMAB [INN]

TORIPALIMAB [USAN]

TORIPALIMAB [WHO-DD]

TORIPALIMAB TPZI [WHO-DD]

TREPRIZUMAB

TRIPLEITRIUMAB

TRIPRIZUMAB